{"id":182131,"date":"2018-01-22T00:00:00","date_gmt":"2018-01-21T23:00:00","guid":{"rendered":"https:\/\/www.bcfi.be\/probiotiques-contenant-saccharomyces-boulardii-le-medicament-enterol-et-divers-complements-alimentaires-desormais-contre-indiques-chez-les-patients-gravement-malades-et-les-patients-imm\/"},"modified":"2018-01-22T00:00:00","modified_gmt":"2018-01-21T23:00:00","slug":"probiotiques-contenant-saccharomyces-boulardii-le-medicament-enterol-et-divers-complements-alimentaires-desormais-contre-indiques-chez-les-patients-gravement-malades-et-les-patients-imm","status":"publish","type":"post","link":"https:\/\/h.cbip.be\/fr\/probiotiques-contenant-saccharomyces-boulardii-le-medicament-enterol-et-divers-complements-alimentaires-desormais-contre-indiques-chez-les-patients-gravement-malades-et-les-patients-imm\/","title":{"rendered":"Probiotiques contenant Saccharomyces boulardii (le m\u00e9dicament Enterol\u00ae et divers compl\u00e9ments alimentaires): d\u00e9sormais contre-indiqu\u00e9s chez\u00a0 les patients gravement malades et les patients immunod\u00e9prim\u00e9s"},"content":{"rendered":"<p>Les probiotiques contenant <em>Saccharomyces boulardii<\/em> (le m\u00e9dicament Enterol\u00ae et divers compl\u00e9ments alimentaires) sont d\u00e9sormais contre-indiqu\u00e9s chez les patients malades dans un \u00e9tat critique et chez les patients immunod\u00e9prim\u00e9s. Cette nouvelle contre-indication fait suite \u00e0 l\u2019analyse&#x002C; au niveau europ\u00e9en&#x002C; des rapports de cas d\u2019infection syst\u00e9mique \u00e0 <em>S. boulardii<\/em> chez de tels patients&#x002C; parfois accompagn\u00e9e d\u2019une fong\u00e9mie potentiellement fatale. La nouvelle contre-indication est plus large que celle mentionn\u00e9e actuellement dans le RCP de Enterol\u00ae (contre-indication limit\u00e9e aux patients porteurs d&#39;un cath\u00e9ter veineux central).\u00a0<\/p>\n<p>Lire plus sur \u00a0<a href=&quot;https:\/\/www.afmps.be\/fr\/news\/flash_vig_news_saccharomyces_boulardii_en_belgique_enterolr_risque_de_fongemie_et_contre&quot;>https:\/\/www.afmps.be\/fr\/news\/flash_vig_news_saccharomyces_boulardii_en_belgique_enterolr_risque_de_fongemie_et_contre<\/a> et <a href=&quot;https:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Minutes\/2017\/11\/WC500239285.pdf&quot;>www.ema.europa.eu\/docs\/en_GB\/document_library\/Minutes\/2017\/11\/WC500239285.pdf<\/a> (terme de recherche: \u201cSaccharomyces\u201d).<\/p>\n<p> \u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Les probiotiques contenant Saccharomyces boulardii (le m\u00e9dicament Enterol\u00ae et divers  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,63],"tags":[20213],"class_list":["post-182131","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2018-fr","tag-import_tags"],"_links":{"self":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/182131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=182131"}],"version-history":[{"count":0,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/posts\/182131\/revisions"}],"wp:attachment":[{"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=182131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=182131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h.cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=182131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}